Abstract
The goal of this study was to identify antibiotics with potential risk in river water of the megacity Beijing, China. This was accomplished by using a tiered approach that combined hazard (phase I) and monitoring-based risk (phase II) assessment. Ninety-five candidate antibiotics were screened and 31 was identified as hazardous during phase I assessment. Of these hazardous antibiotics, 29 were identified as persistent and 7 were identified as bioaccumulative antibiotics. Fluoroquinolones, macrolides, sulfonamides, and aminoglycosides account for over 80% of these hazardous antibiotics. During phase II, four antibiotics (erythromycylamine, cefotaxime, ampicillin, and fusidic acid) that were not previously reported were detected in the surface water sampled from four major rivers in Beijing, with concentrations ranging from not detected to approximately 300 ng/L. The ecological risk assessment showed that erythromycylamine, cefotaxime, and ampicillin posed low to high levels of risk to the aquatic organisms. To summarize, erythromycylamine, cefotaxime, and ampicillin were identified as priority antibiotics in rivers in Beijing, China. Our results demonstrated the necessity of conducting monitoring-based verification process in identification of priority antibiotics in a specific region.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Al-Khazrajy OSA, Boxall ABA (2016) Risk-based prioritization of pharmaceuticals in the natural environment in Iraq. Environ Sci Pollut Res 23:15712–15726
Ankley GT, Brooks BW, Huggett DB, Sumpter JP (2007) Repeating history: pharmaceuticals in the environment. Environ Sci Technol 41:8211–8217
Arpin-Pont L, Bueno MJ, Gomez E, Fenet H (2016) Occurrence of PPCPs in the marine environment: a review. Environ Sci Pollut Res 23:4978–4991
Berninger JP, LaLone CA, Villeneuve DL, Ankley GT (2016) Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset. Environ Toxicol Chem 35:1007–1020
Boxall ABA, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, Innes E, Ostapyk K, Staveley JP, Verslycke T, Ankley GT, Beazley KF, Belanger SE, Berninger JP, Carriquiriborde P, Coors A, DeLeo PC, Dyer SD, Ericson JF, Gagne F, Giesy JP, Gouin T, Hallstrom L, Karlsson MV, Larsson DGJ, Lazorchak JM, Mastrocco F, McLaughlin A, McMaster ME, Meyerhoff RD, Moore R, Parrott JL, Snape JR, Murray-Smith R, Servos MR, Sibley PK, Straub JO, Szabo ND, Topp E, Tetreault GR, Trudeau VL, Van Der Kraak G (2012) Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 120:1221–1229
Bu Q, Wang B, Huang J, Deng S, Yu G (2013a) Pharmaceuticals and personal care products in the aquatic environment in China: a review. J Hazard Mater 262:189–211
Bu QW, Wang DH, Wang ZJ (2013b) Review of screening systems for prioritizing chemical substances. Crit Rev Environ Sci Technol 43:1011–1041
Bu Q, Cao Y, Yu G, He X, Zhang H, Sun J, Yun M, Cao Z (2020) Identifying targets of potential concern by a screening level ecological risk assessment of human use pharmaceuticals in China. Chemosphere 246:125818
Burns EE, Thomas-Oates J, Kolpin DW, Furlong ET, Boxall ABA (2017) Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose? Environ Toxicol Chem 36:2823–2832
Chen YL, Sng WJ, Wang D, Wang XY (2019) Antibiotic overuse and allergy-related diseases: an epidemiological cross-sectional study in the grasslands of Northern China. Ther Clin Risk Manag 15:783–789
Daughton CG (2010) Pharmaceutical ingredients in drinking water: overview of occurrence and significance of human exposure. Contaminants of emerging concern in the environment: ecological and human health considerations. ACS Symp Ser 1048:9–68
Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907–938
Ebele AJ, Abou-Elwafa Abdallah M, Harrad S (2017) Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerg Contan 3:1–16
EC (2003) Council regulation (EEC) No. 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances
Geerdes-Fenge HF, Goetschi B, Rau M, Borner K, Koeppe P, Wettich K, Lode H (1997) Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva. Eur J Clin Pharmacol 53:127–133
Helwig K, Hunter C, McNaughtan M, Roberts J, Pahl O (2016) Ranking prescribed pharmaceuticals in terms of environmental risk: inclusion of hospital data and the importance of regular review. Environ Toxicol Chem 35:1043–1050
Hernando MD, Rodríguez A, Vaquero JJ, Fernández-Alba AR, García E (2011) Environmental risk assessment of emerging pollutants in water: approaches under horizontal and vertical EU legislation. Crit Rev Environ Sci Technol 41:699–731
Howard PH, Muir DCG (2011) Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals. Environ Sci Technol 45:6938–6946
Huang Q, Bu Q, Zhong W, Shi K, Cao Z, Yu G (2018) Derivation of aquatic predicted no-effect concentration (PNEC) for ibuprofen and sulfamethoxazole based on various toxicity endpoints and the associated risks. Chemosphere 193:223–229
Ji K, Han EJ, Back S, Park J, Ryu J, Choi K (2016) Prioritizing human pharmaceuticals for ecological risks in the freshwater environment of Korea. Environ Toxicol Chem 35:1028–1036
Kumar A, Xagoraraki I (2010) Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Sci Total Environ 408:5972–5989
Li Y, Zhang L, Ding J, Liu X (2020) Prioritization of pharmaceuticals in water environment in China based on environmental criteria and risk analysis of top-priority pharmaceuticals. J Environ Manag 253:109732
Liu J-L, Wong M-H (2013) Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ Int 59:208–224
Mansour F, Al-Hindi M, Saad W, Salam D (2016) Environmental risk analysis and prioritization of pharmaceuticals in a developing world context. Sci Total Environ 557-558:31–43
MIIT (2012) China Medical Statistics 2011. Ministry of Industry and Information Technology of the People’s Republic of China, Beijing
MIIT (2013) China Medical Statistics 2012. Ministry of Industry and Information Technology of the People’s Republic of China, Beijing
MIIT (2014) China Medical Statistics 2013. Ministry of Industry and Information Technology of the People’s Republic of China, Beijing
MIIT (2015) China Medical Statistics 2014. Ministry of Industry and Information Technology of the People’s Republic of China, Beijinsg
MIIT (2016) China Medical Statistics 2015. Ministry of Industry and Information Technology of the People’s Republic of China, Beijing
Monteiro SC, Boxall AB (2010) Occurrence and fate of human pharmaceuticals in the environment. Rev Environ Contam Toxicol. Springer, New York, pp. 53–154
Peng FJ, Pan CG, Zhang M, Zhang NS, Windfeld R, Salvito D, Selck H, Van den Brink PJ, Ying GG (2017) Occurrence and ecological risk assessment of emerging organic chemicals in urban rivers: Guangzhou as a case study in China. Sci Total Environ 589:46–55
Sangion A, Gramatica P (2016) PBT assessment and prioritization of contaminants of emerging concern: pharmaceuticals. Environ Res 147:297–306
Snyder SA, Westerhoff P, Yoon Y, Sedlak DL (2003) Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ Eng Sci 20:449–469
Sui Q, Wang B, Zhao W, Huang J, Yu G, Deng S, Qiu Z, Lu S (2012) Identification of priority pharmaceuticals in the water environment of China. Chemosphere 89:280–286
Sui Q, Cao X, Lu S, Zhao W, Qiu Z, Yu G (2015) Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: a review. Emerg Contan 1:14–24
USEPA (2018) Estimation Programs Interface Suite™ for Microsoft® Windows. v 4.11. United States Environmental Protection Agency, Washington, DC, USA
Veronica Z, Monnier AA, Gyssens IC, Niels A, Ann V, Céline P, Le MM, Gianpiero T, Vera V-P, Mirjana SB (2018) Variation in antibiotic use among and within different settings: a systematic review. J Antimicrob Chemother 73:17–29
Zhang QH, Yang WN, Ngo HH, Guo WS, Jin PK, Dzakpasu M, Yang SJ, Wang Q, Wang XC, Ao D (2016) Current status of urban wastewater treatment plants in China. Environ Int 92-93:11–22
Zhou H, Zhang Q, Wang X, Zhang Q, Ma L, Zhan Y (2014) Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control. Environ Sci Pollut Res Int 21:7113–7129
Acknowledgments
We acknowledge the support provided by China Scholarship Council during a visit of Qingwei Bu to the University of Georgia. We thank Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
Funding
This work was co-supported by the National Natural Science Foundation of China (grant no. 21777188) and the Fundamental Research Funds for the Central Universities in China (grant no. 2020YJSHH20). Qingwei Bu was also funded by Yue Qi Young Scholar Project, China University of Mining & Technology, Beijing (grant no. 2017QN15).
Author information
Authors and Affiliations
Contributions
Qingwei Bu designed, planned, conceptualized, performed the analysis, drafted the original manuscript, funding acquisition, and project administered, Hongmei Cao was involved in performing the analysis, and drafting the original manuscript; Qingshan Li and Handan Zhang were involved in statistical analysis, and proofreading; Weiwei Jiang was involved in planning and designing the research; Gang Yu was involved in interpretation, and consultation to write a draft manuscript. All authors have approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Responsible editor: Hongwen Sun
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 236 kb)
Rights and permissions
About this article
Cite this article
Bu, Q., Cao, H., Li, Q. et al. Identifying unknown antibiotics with persistent and bioaccumulative properties and ecological risk in river water in Beijing, China. Environ Sci Pollut Res 28, 13515–13523 (2021). https://doi.org/10.1007/s11356-020-11611-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-020-11611-4